Patents by Inventor Rene Devos

Rene Devos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HCV nucleoside derivatives
    Publication number: 20040110718
    Abstract: The present invention comprises novel and known purine and pyrimidine nucleoside derivatives which have been discovered to be active against hepatitis C virus (HCV). The use of these derivatives for the treatment of HCV infection is claimed as are the novel nucleoside derivatives disclosed herein.
    Type: Application
    Filed: October 3, 2003
    Publication date: June 10, 2004
    Inventors: Rene Devos, Brian William Dymock, Christopher John Hobbs, Wen-Rong Jiang, Joseph Armstrong Martin, John Herbert Merrett, Isabel Najera, Nobuo Shimma, Takuo Tsukuda
  • Anti-HCV nucleoside derivatives
    Publication number: 20030008841
    Abstract: The present invention comprises novel and known purine and pyrimidine nucleoside derivatives which have been discovered to be active against hepatitis C virus (HCV). The use of these derivatives for the treatment of HCV infection is claimed as are the novel nucleoside derivatives disclosed herein.
    Type: Application
    Filed: August 7, 2001
    Publication date: January 9, 2003
    Inventors: Rene Devos, Brian William Dymock, Christopher John Hobbs, Wen-Rong Jiang, Joseph Armstrong Martin, John Herbert Merrett, Isabel Najera, Nobuo Shimma, Takuo Tsukuda
  • Pegylated obese (ob) protein compositions
    Patent number: 6025324
    Abstract: Polyethylene and polypropylene protein conjugates which modulate body weight of ani is and humans for the treatment, prevention and control obesity and associated diseases or conditions, and the recombinant expression of these biologically active proteins in purified and homogeneous forms.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: February 15, 2000
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Pascal Sebastian Bailon, Arthur Campfield, Rene Devos, Yves Guisez
  • Pegylated obese (ob) protein compositions
    Patent number: 6025325
    Abstract: Polyethylene and polypropylene protein conjugates which modulate body weight of animals and humans for the treatment, prevention and control of obesity and associated diseases or conditions, and the recombinant expression of these biologically active proteins in purified and homogeneous forms.
    Type: Grant
    Filed: May 15, 1996
    Date of Patent: February 15, 2000
    Assignee: Hoffman-La Roche Inc.
    Inventors: Arthur Campfield, Rene Devos, Yves Guisez
  • Recombinant obese (ob) proteins
    Patent number: 5968779
    Abstract: Proteins which modulate body weight of animals and humans for the treatment, prevention and control of obesity and associated diseases or conditions, and the recombinant expression of these biologically active proteins in purified and homogeneous forms.
    Type: Grant
    Filed: January 5, 1998
    Date of Patent: October 19, 1999
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Arthur Campfield, Rene Devos, Yves Guisez
  • Chimeric interleukin 5-receptor/immunoglobulin polypeptides
    Patent number: 5712121
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.-and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy--or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: January 27, 1998
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier
  • Chimeric interleukin 5-receptor/immunoglobulin polypeptides
    Patent number: 5668256
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.- and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy- or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: September 16, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier
  • DNA encoding chimeric polypeptides comprising the interleukin-5 receptor .alpha.-chain fused to immunoglobulin heavy chain constant regions
    Patent number: 5455337
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.- and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy- or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: September 16, 1992
    Date of Patent: October 3, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier